{"id":null,"code":"DRUG0008","name":{"valueFi":"Therapy Areas in Drug Discovery and Translational Medicine I","valueEn":"Therapy Areas in Drug Discovery and Translational Medicine I","valueSv":"Therapy Areas in Drug Discovery and Translational Medicine I"},"credits":5.0,"minCredits":5,"maxCredits":5,"tags":[],"createdAt":1790534678515,"contentList":[{"title":{"valueFi":"Osaamistavoitteet","valueEn":"Learning outcomes","valueSv":""},"content":{"valueFi":"On successful completion of this study module, students will be able to:\r\n•\tDescribe pathophysiological disease mechanisms, diagnostic methods and biomarkers as well as clinical symptoms of diseases in the selected main therapy areas\r\n•\tExplain the mechanisms of action of currently used drugs and critically assess their utility in the treatment of these diseases\r\n•\tIdentify existing unmet medical needs\r\n•\tComprehend how animal disease models are produced and employed in the development of new drugs and how translational medicine approaches are used to facilitate the entry of drug candidates into clinical development\r\n•\tCommunicate effectively with specialists and peers","valueEn":"On successful completion of this study module, students will be able to:\r\n•\tDescribe pathophysiological disease mechanisms, diagnostic methods and biomarkers as well as clinical symptoms of diseases in the selected main therapy areas\r\n•\tExplain the mechanisms of action of currently used drugs and critically assess their utility in the treatment of these diseases\r\n•\tIdentify existing unmet medical needs\r\n•\tComprehend how animal disease models are produced and employed in the development of new drugs and how translational medicine approaches are used to facilitate the entry of drug candidates into clinical development\r\n•\tCommunicate effectively with specialists and peers","valueSv":"On successful completion of this study module, students will be able to:\r\n•\tDescribe pathophysiological disease mechanisms, diagnostic methods and biomarkers as well as clinical symptoms of diseases in the selected main therapy areas\r\n•\tExplain the mechanisms of action of currently used drugs and critically assess their utility in the treatment of these diseases\r\n•\tIdentify existing unmet medical needs\r\n•\tComprehend how animal disease models are produced and employed in the development of new drugs and how translational medicine approaches are used to facilitate the entry of drug candidates into clinical development\r\n•\tCommunicate effectively with specialists and peers"}},{"title":{"valueFi":"Sisältö","valueEn":"Content","valueSv":""},"content":{"valueFi":"The course covers topics from the major Central Nervous System (CNS) disease area (like Alzheimer’s disease, Parkinson’s disease, depression, addiction, schizophrenia, multiple sclerosis)\r\n•\tPathophysiological mechanisms and etiology\r\n•\tDiagnostic criteria, clinical signs and symptoms\r\n•\tCurrent drug therapy\r\n•\tAnimal models\r\n•\tEmerging new targets and an overview of the pipeline situation","valueEn":"The course covers topics from the major Central Nervous System (CNS) disease area (like Alzheimer’s disease, Parkinson’s disease, depression, addiction, schizophrenia, multiple sclerosis)\r\n•\tPathophysiological mechanisms and etiology\r\n•\tDiagnostic criteria, clinical signs and symptoms\r\n•\tCurrent drug therapy\r\n•\tAnimal models\r\n•\tEmerging new targets and an overview of the pipeline situation\r\n\r\nEach section is followed by questions and discussions.","valueSv":"The course covers topics from the major Central Nervous System (CNS) disease area (like Alzheimer’s disease, Parkinson’s disease, depression, addiction, schizophrenia, multiple sclerosis)\r\n•\tPathophysiological mechanisms and etiology\r\n•\tDiagnostic criteria, clinical signs and symptoms\r\n•\tCurrent drug therapy\r\n•\tAnimal models\r\n•\tEmerging new targets and an overview of the pipeline situation"}},{"title":{"valueFi":"Suoritustavat","valueEn":"Study methods","valueSv":""},"content":{"valueFi":"As the entire study module is based on self-guidance of students and self-managed teams, only the main topics are given in advance. Students are divided into groups of five or six. Each group will study and create a presentation on the topic of the week, and present their work in seminars. Seminar attendance is mandatory.  \r\nIn addition, there will be mandatory Introduction to research groups -seminar (with hybrid and/or recorded presentations) where local research groups are presenting their research projects and activities including methodological aspects of their research.","valueEn":"As the entire study module is based on self-guidance of students and self-managed teams, only the main topics are given in advance. Students are divided into groups of five or six. Each group will study and create a presentation on the topic of the week, and present their work in seminars. Seminar attendance is mandatory.\r\nIn addition, there will be mandatory Introduction to research groups -seminar (with hybrid and/or recorded presentations) where local research groups are presenting their research projects and activities including methodological aspects of their research.","valueSv":""}},{"title":{"valueFi":"Toteutustavat","valueEn":"Course unit methods","valueSv":""},"content":{"valueFi":"Lectures (2 h), small group work (self-study, creating presentations as a group approx. 106 h), mandatory presence in seminars (approx. 20 h), examination (2 h)","valueEn":"Lectures (2 h), small group work (self-study, creating presentations as a group approx. 106 h), mandatory presence in seminars (approx. 20 h), examination (2 h)","valueSv":""}},{"title":{"valueFi":"Oppimateriaalit","valueEn":"Learning material","valueSv":""},"content":{"valueFi":"Relevant textbooks and recent review articles of the topics. Public databases and pipelines of drug discovery companies.","valueEn":"Relevant textbooks and recent review articles of the topics. Public databases and pipelines of drug discovery companies.","valueSv":""}},{"title":{"valueFi":"Lisätiedot","valueEn":"Further information","valueSv":""},"content":{"valueFi":"Minor students are selected on the basis of their application and previous relevant studies in pharmacology. 1-5 minor students are accepted for the course","valueEn":"Minor students are selected on the basis of their application and previous relevant studies in pharmacology. 1-5 minor students are accepted for the course","valueSv":""}},{"title":{"valueFi":"Kurssikirjallisuus","valueEn":"Literature","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}},{"title":{"valueFi":"Esitietovaatimukset","valueEn":"Qualifications","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}},{"title":{"valueFi":"Arviointiasteikko","valueEn":"Assessment scale","valueSv":""},"content":{"valueFi":"0-5","valueEn":"0-5","valueSv":"0-5"}},{"title":{"valueFi":"Arviointikriteerit","valueEn":"Assessment criteria","valueSv":""},"content":{"valueFi":"Evaluation criteria are based on: a) knowledge of the entire area of the study module, as measured by a written examination (60 % of the total grade), b) quality of seminar presentations and activity (40 % of the total grade),","valueEn":"Evaluation criteria are based on: a) knowledge of the entire area of the study module, as measured by a written examination (60 % of the total grade), b) quality of seminar presentations and activity (40 % of the total grade),","valueSv":""}},{"title":{"valueFi":"Arviointikriteerit 2","valueEn":"Assessment criteria 2","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}},{"title":{"valueFi":"Arviointikriteerit 3","valueEn":"Assessment criteria 3","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}},{"title":{"valueFi":"Arviointikriteerit 4","valueEn":"Assessment criteria 4","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}},{"title":{"valueFi":"Kielet","valueEn":"Languages","valueSv":""},"content":{"valueFi":"englanti","valueEn":"English","valueSv":"engelska"}},{"title":{"valueFi":"Taso","valueEn":"Level","valueSv":""},"content":{"valueFi":"Syventävät opinnot","valueEn":"Advanced Studies","valueSv":""}},{"title":{"valueFi":"Oppiaine","valueEn":"Subject","valueSv":""},"content":{"valueFi":"Drug Discovery and Development","valueEn":"Drug Discovery and Development","valueSv":"Drug Discovery and Development"}},{"title":{"valueFi":"Vastuuhenkilöt","valueEn":"Person in charge","valueSv":""},"content":{"valueFi":"Sanna Soini","valueEn":"Sanna Soini","valueSv":"Sanna Soini"}},{"title":{"valueFi":"Luokittelu","valueEn":"Classification","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}},{"title":{"valueFi":"Linkit","valueEn":"Links","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}}]}